Cormorant Asset Management, LP Icosavax, Inc. Transaction History

Cormorant Asset Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.09 - $9.21 $23,385 - $69,701	-7,568 Reduced 1.16%	643,825 $2.03 Million
Q2 2022 Aug 15, 2022	BUY	$5.7 - $10.33 $1.28 Million - $2.32 Million	225,000 Added 52.77%	651,393 $3.73 Million
Q3 2021 Nov 15, 2021	BUY	$24.85 - $40.25 $10.6 Million - $17.2 Million	426,393 New	426,393 $12.2 Million

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.